1. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis
    Jianhua Feng et al, 2018, Endocrine CrossRef
  2. What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography?
    Haejung Kim et al, 2022, Ultrasonography CrossRef
  3. Molecular Pathology of Endocrine Tumors
    Lori A. Erickson, 2023, Molecular Surgical Pathology CrossRef
  4. Preoperative Typing of Thyroid and Parathyroid Tumors with a Combined Molecular Classifier
    Sergei E. Titov et al, 2021, Cancers CrossRef
  5. Tall Cell Subtype of Papillary Thyroid Carcinoma
    Lan Chen, 2023, Thyroid FNA Cytology CrossRef
  6. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases
    Nadjla Alsadoun et al, 2018, Modern Pathology CrossRef
  7. Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience
    Agnese Proietti et al, 2023, Cancers CrossRef
  8. Papillary Thyroid Carcinoma, Tall Cell Variant
    Vania Nosé, 2018, Diagnostic Pathology: Endocrine CrossRef
  9. hMTH1 and GPX1 expression in human thyroid tissue is interrelated to prevent oxidative DNA damage
    Katarzyna D. Arczewska et al, 2020, DNA Repair CrossRef
  10. Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification
    Yanhua Bai et al, 2020, Endocrinology and Metabolism CrossRef
  11. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma
    Daniel John et al, 2023, International Journal of Molecular Sciences CrossRef
  12. Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study
    Luca Filippi et al, 2021, Diagnostics CrossRef
  13. A case-based approach to aggressive variants of papillary thyroid carcinoma with literature review
    JosephAntoine Flordelis Chatto et al, 2019, Thyroid Research and Practice CrossRef
  14. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis
    Shabnam Samankan et al, 2022, Pathology - Research and Practice CrossRef
  15. Recent Advances in the Classification of Low-grade Papillary-like Thyroid Neoplasms and Aggressive Papillary Thyroid Carcinomas: Evolution of Diagnostic Criteria
    Zhenying Guo et al, 2018, Advances in Anatomic Pathology CrossRef
  16. Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
    Paula Soares et al, 2021, Endocrine Pathology CrossRef
  17. Overview of the 2022 WHO Classification of Thyroid Neoplasms
    Zubair W. Baloch et al, 2022, Endocrine Pathology CrossRef
  18. Different Threshold of Malignancy for RAS-like Thyroid Tumors Causes Significant Differences in Thyroid Nodule Practice
    Kennichi Kakudo, 2022, Cancers CrossRef
  19. Aggressive Subtypes of PTC: How to Handle Them in FNA Cytology
    Annette Salillas, 2023, Thyroid FNA Cytology CrossRef
  20. Tall cell papillary thyroid micro carcinoma: case report and review of the subject
    Ulises Parada et al, 2023, Journal of Cancer Prevention & Current Research CrossRef